A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
Regor Pharmaceuticals Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Genmab
Fate Therapeutics
Epsilogen Ltd
IDEAYA Biosciences
Avera McKennan Hospital & University Health Center
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
AstraZeneca
SystImmune Inc.
Terremoto Biosciences Inc.
Institut Paoli-Calmettes
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Eli Lilly and Company
Radiopharm Theranostics, Ltd
Myeloid Therapeutics
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Medical College of Wisconsin
Elephas
Dren Bio
Mayo Clinic